SCP-5579
Unknown
~
medium confidence
SCP-5579
Expected annual
$16.5M
One-time setup
$228.9M
Annual recurring
$11.0M
Personnel
15
Initial capital requirements are large (~$229M one-time) due primarily to contingency reserves, industry buyouts and potential full replacement programs; baseline recurring operations cost about $11M/year driven by core research staff, surveillance/diagnostics, greenhouse operations and security.
One-Time Capital Costs
Total: $228.9M
Annual Recurring Costs
Total: $11.0M/yr
Cost Scenarios
📊
Baseline
(baseline)
$11.0M/yr
Normal operational year with no major incidents; routine research, surveillance and maintenance only.
no detected outbreaks
routine surveillance only
🚨
Minor Incident
$16.0M/yr
Localized contamination or positive detections requiring targeted recalls, surge testing and field response.
localized positive tests
small-scale recall/cleanup
🚨
Major Breach
$131.0M/yr
Widespread supply-chain contamination or public leak requiring mass recalls, large buyouts and international emergency response.
widespread contamination
major public disclosure
🚨
Replacement Program
$161.0M/yr
Policy decision to forcibly replace commercial tapioca supply with SCP-resistant cultivars in a single-year accelerated program.
policy-level forced replacement
large-scale agricultural intervention
Personnel
15 total
| Role | Count | Notes |
|---|---|---|
| Project Lead / Principal Investigator | 1 | [#5] Senior leadership for interdisciplinary project (budgeted within staff wages). |
| Research Scientist (Senior) | 5 | [#5] Senior plant geneticists/xenobiologists/microbiologists (part of core research payroll). |
| Laboratory Technician | 8 | [#5] Lab techs for culture handling, assays and greenhouse support (part of core research payroll). |
| Data Manager / Bioinformatics | 1 | [#5] Data manager handling sequencing, LIMS and surveillance datasets (part of core research payroll). |
Confidence Notes
Analyst notes provide detailed line items and ranges, enabling a defensible mid-range estimate; however large uncertainties remain around rare high-impact scenarios (industry buyouts, replacement programs, catastrophic containment failure), so overall confidence is medium.